Search Within

Gria N Jacobs

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (6)
  2. Center for Pancreatic Cancer Research (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. Gastrointestinal Oncology Service (6)
  6. Solid Tumor Oncology Division (6)

More Groups

People
  1. Ghassan Abou-Alfa (6)
  2. Marinela Capanu (6)
  3. David Kelsen (4)
  4. Eileen O'Reilly (4)
  5. Bolorsukh Gansukh (3)
  6. Gary Schwartz (3)

More People

Years
  1. 2012 (1)
  2. 2011 (1)
  3. 2008 (2)
  4. 2007 (1)
  5. 2006 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. American Journal of Clinical Oncology (1)
  3. Annals of Oncology (1)
  4. Gastrointestinal Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. International Society of Gastrointestinal Oncology (1)
  3. Lippincott Williams & Wilkins (1)
  4. Oxford University Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine
    Journal Article

    Abou-Alfa, G. K.; Chapman, P. B.; Feilchenfeldt, J.; Brennan, M. F.; Capanu, M.; Gansukh, B.; Jacobs, G.; Levin, A.; Neville, D.; Kelsen, D. P.; more...
    American Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Correlation of history of tobacco consumption and type of k-ras mutation in patients (pts) with pancreatic adenocarcinoma (PC)
    Meeting Abstract

    Kelsen, D. P.; O'Reilly, E. M.; Huitzil Melendez, F. D.; Zheng, J.; Capanu, M.; Duffy, A.; Gansukh, B.; Jacobs, G.; Chapman, P. B.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Tumor necrosis as a correlate for response in subgroup of patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib
    Meeting Abstract

    Abou-Alfa, G. K.; Zhao, B.; Capanu, M.; Guo, P.; Liu, F.; Jacobs, G.; Gansukh, B.; Moscovici, M.; Lentini, G.; Schwartz, L.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Abou-Alfa, G. K.; Carvajal, R. D.; Chung, K. Y.; Ghossein, R. A.; Capanu, M.; Gonen, M.; Jacobs, G.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save